Marken continues expansion with Buenos Aires facility

Tuesday, December 20, 2011 01:39 PM

Marken continues their expansion of services in Latin America, by augmenting their new purpose-built Buenos Aires facility.

"The expansion of our services in Latin America enables our clients to better recruit in treatment naive populations and work with previously unreachable investigator sites, assuring quality and regulatory documentation through the entire supply chain." said Wes Wheeler, Marken's chief executive officer.

Marken is implementing their stated plan to build an advanced, fit for purpose clinical distribution network to serve the pharmaceutical community. The new Argentina depot builds on Marken's current Latin America business which serves over 1200 clinical research investigator sites in the region, and enables the company to grow from its current industry-leading life sciences logistics platform. Marken is developing further depot facilities in Europe, Asia and the Americas.

The Argentina depot joins Marken's already operational Mexico and Singapore depots offering the full range of temperature controlled storage capabilities. Each of Marken's depots provides drug and equipment distribution solutions. Additionally the network manages specimen kit distribution, interim specimen storage and management.

Share:          
CWWeekly

April 13

Quintiles-Quest Diagnostics joint venture latest in CRO-central lab deals, more could be on horizon

Biotech companies raise record amount of capital in Q1

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs